Vijaya Raj Bhatt, M.D.
Assistant Professor, Internal Medicine
Division of Oncology & Hematology
Academic office mailing address:
UNMC Oncology/Hematology Division
986840 Nebraska Medical Center
Omaha, NE 681980-6840
Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)
Bellevue Medical Center Clinic
2500 Bellevue Medical Center Dr., Suite 250
Bellevue, NE 68123
Ph. 402-595-1984 (map)
Bachelor in Medicine and Bachelor in Surgery (MBBS), Tribhuvan University, Nepal (2009)
Residency in Internal Medicine, Staten Island University Hospital, New York (2012)
Fellowship in Hematology-Oncology, University of Nebraska Medical Center, Nebraska (2015)
Bellevue Medical Center
Hematopoietic stem cell transplant, post-transplant complications, graft-versus-host disease, Leukemia, myeloid disorders, benign hematologic disorders
Membership in Societies:
ASCO, ASH, ASBMT
Dr. Vijaya Raj Bhatt graduated from Institute of Medicine, Tribhuvan University in Nepal in 2009 with a degree of Bachelor of Medicine and Bachelor of Surgery (MBBS). He then went on to do a three-year residency in internal medicine in Staten Island University Hospital in Staten Island, New York. During his residency, he was awarded the resident of the year for three consecutive years. After completing his residency, he joined the University of Nebraska Medical Center in Nebraska and completed his fellowship in hematology-oncology. He has authored or co-authored 127 articles, 18 book chapters and 98 abstracts. He has presented widely at several national and international meetings of professional societies. During his residency, he was awarded the resident physician research award 2010-2011 and the resident teacher of the year award 2011-2012. During his fellowship, he was awarded the internal medicine fellowship research award, 2014. He is also a recipient of 2015-16 and 2016-17 Physician-Scientist Training Program Grant from the College of Medicine, University of Nebraska Medical Center. He is currently involved in research related to hematopoietic stem cell transplant, graft-versus-host disease, leukemia and other malignant and benign hematological disorders. He lives in West Omaha with his wife, Sujana Panta and son, Suvidh Bhatta.
Dhakal P, Bhatt VR. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy? Bone Marrow Transplant. 2016 Oct [Epub ahead of print]
Khanal N, Bociek RG, Chen B, Vose JM, Armitage JO, Bierman PJ, Maness LJ, Lunning MA, Gundabolu K, Bhatt VR. Venous Thromboembolism in Patients with Hematologic Malignancy and Thrombocytopenia. Am J Hematol. 2016 Nov;91(11):E468-E472.
Adhikari J, Sharma P, Bhatt VR. Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood? Future Oncol. 2016 Aug;12(15):1823-32.
Bhatt VR, Giri S, Verma V, Dahal S, Shah BK, Pathak R, Bociek RG, Vose JV, Armitage JO. Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma. Future Oncol. 2016 Jul;12(13):1565-75.
Giri S, Pathak R, Martin MG, Bhatt VR. Survival of de novo and secondary acute promyelocytic leukemia: A propensity matched analysis of the SEER database. Leuk Lymphoma. 2016;57(2):385-391.
Bhatt VR. Allogeneic Stem Cell Transplantation for Non-Hodgkin Lymphoma. Curr Hematol Malig Rep. 2016 Jun;11(3):196-207.
Verma V, Giri S, Manandhar S, Pathak R, Bhatt VR. Acute promyelocytic leukemia during pregnancy: A systematic review. Leuk Lymphoma. 2016 Mar;57(3):616-22.
Khanal N, Giri S, Upadhayay S, Shostrom VK, Pathak R, Bhatt VR. Risk of Second Primary Malignancies and Survival of Adult Patients with Polycythemia Vera: A United States population-based retrospective study. Leuk Lymphoma. 2016 Jan;57(1):129-33.
Adhikari J, Sharma P, Bhatt VR. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies. Future Oncol. 2015 Dec;11(23):3175-85.
Giri S, Pathak R, Martin MG, Bhatt VR. Incidence of breast cancer among female survivors of Hodgkin Lymphoma: A US population-based trend analysis from 1973-2011. Blood. 2015 Oct 8;126(15):1861-3.
Additional Publications at PubMed.Gov: https://www.ncbi.nlm.nih.gov/pubmed